Myovant Sciences

+$0.54 (+2.70%) Today
-$1.15 (-5.60%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYOV and other ETFs, options, and stocks.

About MYOV

Myovant Sciences, Inc. is a clinical-stage biopharmaceutical company. The firm focuses on the development and commercialization of therapies for the treatment of women's health and endocrine diseases.

CEO
David C. Marek
Employees
407
Headquarters
London, Greater London
Founded
2016

MYOV Key Statistics

Market Cap
2.24B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.00M
High Today
$20.59
Low Today
$19.76
Open Price
$20.04
Volume
534.92K
52 Week High
$30.90
52 Week Low
$13.42

MYOV News

BenzingaJul 28

Recap: Myovant Sciences Q1 Earnings

Shares of Myovant Sciences (NYSE:MYOV) rose 1.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 8
BenzingaJul 27

Myovant Sciences's Earnings: A Preview

On Wednesday, July 28, Myovant Sciences (NYSE:MYOV) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the e

MYOV Earnings

-$0.99
-$0.66
-$0.33
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.33 per share
Actual
-$0.67 per share
Replay Earnings Call
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure